AUTOANTIBODIES AFTER VACCINATION AGAINST PNEUMOCOCCAL AND INFLUENZA INFECTIONS IN CHILDREN AND ADOLESCENTS WITH TYPE I DIABETES MELLITUS


Cite item

Full Text

Abstract

Aim. To study the influence of vaccination against pneumococcal and influenza infections on the levels of autoantibodies to DNA, pancreatic and adrenal tissues as well as on populations of lymphocytes and levels of immunoglobulins in children and adolescents with type I diabetes mellitus (DM1). Materials and methods. One hundred and thirty children and adolescents 2 — 18 years of age were followed during 12 months. One hundred participants were vaccinated against pneumococcal infection with Pneumo 23 vaccine. Twenty-eight of them (28%) were also vaccinated against influenza with subunit vaccine Grippol. Vaccination was performed during intensified insulin treatment. Unvaccinated group consisted from 30 children of the same age. During vaccination 59 (59%) children were in phase of diabetes compensation and 41 (41%) — in phase of subcompensation. Results. In 5 out of 10 participants with high level of antibodies (Abs) to native DNA (n-DNA) before vaccination with Pneumo 23, normalization of this level 1 year after vaccination was noted. Normalization of level of Abs to denaturated DNA (d-DNA) was observed in 2 out of 7 patients with high levels to d-DNA before vaccination. Normalization of level of Abs to n-DNA was observed in 2 out of 3 patients after combined vaccination. It is important to note that vaccination of children in subcompensation phase of DM1 did not result in changes of levels of autoantibodies. One year after vaccination decrease of IgG, IgA, and IgM levels to normal range was noted. Absence of increase of HLA-DR and CD16 levels in postimmunization period in children with DM1 vaccinated even in subcompensation phase is also an indirect evidence of absence of autoimmune process activation. Conclusion. Use of Pneumo 23 vaccine or its combination with Grippol vaccine in patients with DM1 did not result in increase of levels of autoantibodies to n-DNA, d-DNA and pancreatic tissue, was not able to initiate or lead to disease progression as well as positively influenced on the immune response with tendency to normalization of the several arms of the immune system and, at the same time, did not result in activation of autoimmune process.

Full Text

АУТОАНТИТЕЛА У ДЕТЕЙ И ПОДРОСТКОВ С САХАРНЫМ ДИАБЕТОМ 1 ТИПА ПОСЛЕ ВАКЦИНАЦИИ ПРОТИВ ПНЕВМОКОККОВОЙ И ГРИППОЗНОЙ ИНФЕКЦИЙ
×

About the authors

M. P Kostinov

Mechnikov Research Institute of Vaccines and Sera, Moscow; State Medical Academy, Nizhny Novgorod; Tyumen Regional Clinical Hospital for Infectious Diseases, Russia

T. V Skochilova

Mechnikov Research Institute of Vaccines and Sera, Moscow; State Medical Academy, Nizhny Novgorod; Tyumen Regional Clinical Hospital for Infectious Diseases, Russia

V. A Vorobyeva

Mechnikov Research Institute of Vaccines and Sera, Moscow; State Medical Academy, Nizhny Novgorod; Tyumen Regional Clinical Hospital for Infectious Diseases, Russia

A. A Tarasova

Mechnikov Research Institute of Vaccines and Sera, Moscow; State Medical Academy, Nizhny Novgorod; Tyumen Regional Clinical Hospital for Infectious Diseases, Russia

T. I Korovkina

Mechnikov Research Institute of Vaccines and Sera, Moscow; State Medical Academy, Nizhny Novgorod; Tyumen Regional Clinical Hospital for Infectious Diseases, Russia

I. V Lukachev

Mechnikov Research Institute of Vaccines and Sera, Moscow; State Medical Academy, Nizhny Novgorod; Tyumen Regional Clinical Hospital for Infectious Diseases, Russia

I. Yu Yushkova

Mechnikov Research Institute of Vaccines and Sera, Moscow; State Medical Academy, Nizhny Novgorod; Tyumen Regional Clinical Hospital for Infectious Diseases, Russia

N. P Vaneeva

Mechnikov Research Institute of Vaccines and Sera, Moscow; State Medical Academy, Nizhny Novgorod; Tyumen Regional Clinical Hospital for Infectious Diseases, Russia

References

  1. Blom L., Nystrom G., Dahlqnist G. The Swedish childhood diabetes study vaccinations and infections as risk determinants for diabetes in childhood. Diabetologia. 1991, 34 (3): 176—181.
  2. DeStefano F., Mullool J.P., Okoro C.A. et al. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics. 2001, 108: E112.
  3. Graves P.M., Barriga K.J., Norris J.M. et al. Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care. 1999, 22 (1016): 1694—1697.
  4. Hiltunen M., Hyoty H., Leinikki P et al. Low mumps antibody levels induced by mumpsmeasles-rubella vaccinations in type 1 diabetic children. Diabet. Med. 1994, 11 (10): 942—946.
  5. Hiltunen M., Lonnrot M., Hyoty H. Immunization and type 1 diabetes mellitus. Is there a link. Drug safety. 1999, 20: 207—212.
  6. Hviid A., Stellfeld M., Wohltahrt J. et al. Routine childhood vaccinations did not increase the risk of incident type 1 diabetes in Danish children. N. Engl. J. Med. 2004, 350: 1398—1404.
  7. Hyoty H., Hiitunen M., Reumanen A. et al. Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Childhood diabetes in Finland study group. Diabetologia. 1993, 36 (12): 1303—1308.
  8. Lindberg B., Ahltors K., Carlsson A. et al. Previous exposure to measles, mumps, and rubella — but not vaccination during adolescence — correlates to the prevalence of pancreatic and thyroid autoantibodies. Pediatrics. 1999, 104 (1): Е12.
  9. Levitsky L.I. Childhood immunizations and chronic illness. N. Engl. Med. J. 2004, 350 (14): 1380—1382.
  10. Ravel G., Christ M., Liberge P. et al. Effect of two pediatric vaccines on autoimmune diabetes in NOD female mice. Toxicol. Lett. 2003, 146 (1): 93—100.
  11. Savola K. et.al. Autoantibodies associated with type 1 diabetes mellitus persist after diagnosis in children. Diabetologia. 1998, 41 (11): 1293—1297.
  12. Sipetic S.B., Vlajinac H.D., Kocev N.I. et al. The Belgrade childhood diabetes study: a miultivariate analysis of risk determinants for diabetes. Eur. J. Public Health. 2005, 15 (2): 117—122.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2009 Kostinov M.P., Skochilova T.V., Vorobyeva V.A., Tarasova A.A., Korovkina T.I., Lukachev I.V., Yushkova I.Y., Vaneeva N.P.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies